Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Metsera

Request full access

Metsera is a clinical-stage biopharmaceutical company dedicated to leading the next generation of medicines and solutions for obesity and metabolic diseases

New York City, United StatesFounded 2022Biotech & Life Sciences

About Metsera

Metsera is a clinical stage biopharmaceutical company focused on developing innovative medicines and solutions for obesity and metabolic diseases. Founded by Population Health Partners and ARCH Venture Partners, Metsera leverages a proprietary library of over 20,000 incretin and non-incretin peptides and monoclonal antibodies to create potential best-in-class treatments. The company aims to reduce the physical, emotional, and economic burdens of obesity, a significant health and social challenge. Metsera's business model involves accelerating the development of new medicines through extensive R&D and large-scale business processes, targeting both consumers and investors. The company generates revenue by advancing its proprietary medicines through clinical trials and eventually bringing them to market. Metsera serves a diverse client base, including patients suffering from obesity and metabolic diseases, healthcare providers, and investors looking for innovative healthcare solutions. Operating in the biopharmaceutical market, Metsera is committed to making life healthier, happier, and longer through its next-generation medicines, technologies, and support systems.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2025

Metsera in the New York City ecosystem

Live from Dealroom

The Metsera office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

29 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A18 investors entered at this stage

Series B and later11 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Metsera on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.